Barrow, Hanley, Mewhinney & Strauss Portfolio holdings
AUM
$29.7B
This Quarter Return
+3.29%
1 Year Return
+17.22%
3 Year Return
+66.53%
5 Year Return
+163.26%
10 Year Return
+255.57%
AUM
$65.7B
AUM Growth
+$65.7B
(+0.04%)
Cap. Flow
-$1.96B
Cap. Flow
% of AUM
-2.98%
Top 10 Holdings %
Top 10 Hldgs %
24.76%
Holding
355
New
32
Increased
93
Reduced
199
Closed
29
Top Buys
| 1 |
CVS Health
CVS
|
$810M |
| 2 |
Carnival Corp
CCL
|
$498M |
| 3 |
Target
TGT
|
$330M |
| 4 |
Cardinal Health
CAH
|
$290M |
| 5 |
Coca-Cola Europacific Partners
CCEP
|
$221M |
Top Sells
| 1 |
Intel
INTC
|
$570M |
| 2 |
Merck
MRK
|
$495M |
| 3 |
TYC
TYCO INTL PLC COM SHS (IRL)
TYC
|
$336M |
| 4 |
JPMorgan Chase
JPM
|
$301M |
| 5 |
CRH
CRH
|
$280M |
Sector Composition
| 1 | Financials | 21.89% |
| 2 | Healthcare | 20.38% |
| 3 | Industrials | 14.19% |
| 4 | Energy | 11.61% |
| 5 | Technology | 8.98% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Philip Morris
PM
$260B
| $1.83B | 2.79% | 18,830,903 -643,357 | -3% | -$62.5M |
|
2
Johnson Controls International
JCI
$69.9B
| $1.75B | 2.66% | 37,517,268 -1,791,192 | -5% | -$83.3M |
|
|
3
JPMorgan Chase
JPM
$829B
| $1.71B | 2.6% | 25,624,180 -4,513,511 | -15% | -$301M |
|
4
Medtronic
MDT
$119B
| $1.64B | 2.5% | 19,033,448 -2,056,814 | -10% | -$178M |
|
5
Wells Fargo
WFC
$263B
| $1.64B | 2.49% | 37,011,768 -831,029 | -2% | -$36.8M |
|
6
Pfizer
PFE
$141B
| $1.6B | 2.44% | 47,267,043 -1,714,149 | -3% | -$58.1M |
|
7
Verizon
VZ
$186B
| $1.6B | 2.43% | 30,689,076 -1,463,920 | -5% | -$76.1M |
|
8
PNC Financial Services
PNC
$81.7B
| $1.55B | 2.36% | 17,222,414 -1,315,177 | -7% | -$118M |
|
9
RTX Corp
RTX
$212B
| $1.49B | 2.27% | 14,676,652 -496,880 | -3% | -$50.5M |
|
10
Johnson & Johnson
JNJ
$427B
| $1.46B | 2.22% | 12,334,416 -876,175 | -7% | -$104M |
|
11
Qualcomm
QCOM
$173B
| $1.44B | 2.19% | 21,024,535 -573,470 | -3% | -$39.3M |
|
12
Air Products & Chemicals
APD
$65.5B
| $1.41B | 2.15% | 9,392,443 -953,106 | -9% | -$143M |
|
13
Occidental Petroleum
OXY
$46.9B
| $1.4B | 2.13% | 19,143,706 +101,998 | +0.5% | +$7.44M |
|
14
Oracle
ORCL
$635B
| $1.4B | 2.12% | 35,533,375 -694,496 | -2% | -$27.3M |
|
15
ConocoPhillips
COP
$124B
| $1.39B | 2.12% | 32,019,446 +3,485,888 | +12% | +$152M |
|
16
BP
BP
$90.8B
| $1.39B | 2.12% | 39,547,836 -388,724 | -1% | -$13.7M |
|
17
Capital One
COF
$145B
| $1.39B | 2.12% | 19,345,724 -468,363 | -2% | -$33.6M |
|
18
Microsoft
MSFT
$3.77T
| $1.34B | 2.03% | 23,181,015 -1,904,276 | -8% | -$110M |
|
|
19
Cardinal Health
CAH
$35.5B
| $1.26B | 1.92% | 16,250,027 +3,729,921 | +30% | +$290M |
|
20
Bank of America
BAC
$376B
| $1.25B | 1.9% | 79,609,333 -4,452,513 | -5% | -$69.7M |
|
|
ESRX
21
DELISTED
Express Scripts Holding Company
ESRX
| $1.23B | 1.87% | 17,407,316 +2,760,945 | +19% | +$195M |
|
22
Teva Pharmaceuticals
TEVA
$21.1B
| $1.22B | 1.86% | 26,570,988 +3,870,176 | +17% | +$178M |
|
23
Altria Group
MO
$113B
| $1.22B | 1.85% | 19,238,669 -475,402 | -2% | -$30.1M |
|
24
Sanofi
SNY
$121B
| $1.2B | 1.82% | 31,320,327 +3,198,048 | +11% | +$122M |
|
|
25
Merck
MRK
$210B
| $1.16B | 1.77% | 18,581,032 -7,935,038 | -30% | -$495M |
|